Hamlet BioPharma AB publ (XSAT:HAMLET B) Total Liabilities : kr4.76 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Total Liabilities?

Hamlet BioPharma AB publ's Total Liabilities for the quarter that ended in Mar. 2025 was kr4.76 Mil.

Hamlet BioPharma AB publ's quarterly Total Liabilities increased from Sep. 2024 (kr5.12 Mil) to Dec. 2024 (kr5.18 Mil) but then declined from Dec. 2024 (kr5.18 Mil) to Mar. 2025 (kr4.76 Mil).

Hamlet BioPharma AB publ's annual Total Liabilities increased from Jun. 2022 (kr3.72 Mil) to Jun. 2023 (kr7.55 Mil) but then declined from Jun. 2023 (kr7.55 Mil) to Jun. 2024 (kr4.11 Mil).

Hamlet BioPharma AB publ Total Liabilities Historical Data

The historical data trend for Hamlet BioPharma AB publ's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Total Liabilities Chart

Hamlet BioPharma AB publ Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

4.08

9.99

3.72

7.55

4.11

Hamlet BioPharma AB publ Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															4.73	4.11	5.12	5.18	4.76

Hamlet BioPharma AB publ Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hamlet BioPharma AB publ's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.108	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.11

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	68.566	-	64.458
	=	4.11

Hamlet BioPharma AB publ's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.762	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	4.76

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	58.577	-	53.815
	=	4.76

Hamlet BioPharma AB publ Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

7ZT:Germany

Address

Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Website

http://www.hamletpharma.com

Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines